NIH-Funding

By: NCIF30

WriteEdit-Grant Questions Blog - Mon, 12/04/2017 - 11:21

Thanks so much for your prompt response writedit!

Categories: NIH-Funding

Request for Information (RFI): Soliciting Input for the Tribal Health Research Office (THRO) Strategic Plan (FY 2018-2022)

NIH Funding Announcements - Mon, 12/04/2017 - 11:09
Notice NOT-OD-18-110 from the NIH Guide for Grants and Contracts
Categories: NIH-Funding

Obesity and Asthma: Awareness and Self- Management (R01 Clinical Trial Optional)

NIH Funding Announcements - Mon, 12/04/2017 - 10:54
Funding Opportunity PA-18-379 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage research that examines the relationship between asthma, obesity and self-management. It seeks to build the science of obesity, asthma, and self-management awareness.
Categories: NIH-Funding

Understanding Immunopathogenesis of Tuberculosis in HIV-1 Infected and Exposed Children (R01 Clinical Trial Not Allowed)

NIH Funding Announcements - Mon, 12/04/2017 - 04:54
Funding Opportunity RFA-AI-17-039 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage research applications to identify changes in immune mechanisms and markers because of Mycobacterium tuberculosis (Mtb) exposure, infection or disease in pediatric populations exposed to or infected with HIV-1.
Categories: NIH-Funding

NINDS Advanced Postdoctoral Career Transition Award to Promote Diversity in Neuroscience Research (K22) - Clinical Trial Required

NIH Funding Announcements - Mon, 12/04/2017 - 04:42
Funding Opportunity PAR-18-468 from the NIH Guide for Grants and Contracts. The NINDS Advanced Postdoctoral Career Transition Award to Promote Diversity is designed to enhance the participation of highly trained early career investigators from diverse backgrounds underrepresented in neuroscience research. This opportunity provides individuals from diverse backgrounds with strong training in neuroscience with the resources and tools that will help facilitate a transition to a stable and productive independent research position. Individuals from diverse backgrounds underrepresented in neuroscience research are eligible for support under this award if they have doctoral research degrees (Ph.D., Ph.D./M.D. or equivalent) and between 2 and 5 years of postdoctoral prior research training at the time of application. The primary objectives of this Funding Opportunity Announcement (FOA) are to: (1) assist talented scientists from underrepresented groups to transition from postdoctoral training to a secure, independent research position and (2) enhance the conditions that promote establishing a strong and innovative independent program of research.
Categories: NIH-Funding

NINDS Advanced Postdoctoral Career Transition Award to Promote Diversity in Neuroscience Research (K22) - Clinical Trial Not Allowed

NIH Funding Announcements - Mon, 12/04/2017 - 04:42
Funding Opportunity PAR-18-469 from the NIH Guide for Grants and Contracts. The NINDS Advanced Postdoctoral Career Transition Award to Promote Diversity is designed to enhance the participation of highly trained early career investigators from diverse backgrounds underrepresented in neuroscience research. This opportunity provides individuals from diverse backgrounds with strong training in neuroscience with the resources and tools that will help facilitate a transition to a stable and productive independent research position. Individuals from diverse backgrounds underrepresented in neuroscience research are eligible for support under this award if they have doctoral research degrees (Ph.D., Ph.D./M.D. or equivalent) and between 2 and 5 years of postdoctoral prior research training at the time of application. The primary objectives of this Funding Opportunity Announcement (FOA) are to: (1) assist talented scientists from underrepresented groups to transition from postdoctoral training to a secure, independent research position and (2) enhance the conditions that promote establishing a strong and innovative independent program of research.
Categories: NIH-Funding

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trials Optional)

NIH Funding Announcements - Mon, 12/04/2017 - 03:38
Funding Opportunity RFA-CA-18-010 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications to incorporate a new technical approach or instrument developed through support from the NCI Innovative Molecular Analysis Technologies (IMAT) program from currently funded NCI P50 specialized centers to expand upon original research question(s) from specific projects or otherwise accelerate progress for the parent study. Awards from this FOA are meant to incentivize independent validation and accelerate the suitability of these emerging technologies for appropriate research communities. As a component of the NCI IMAT program, this FOA aims to promote interdisciplinary collaboration in the development of innovative tools and methods that enable cancer research and accelerate scientific discovery.
Categories: NIH-Funding

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trials Optional)

NIH Funding Announcements - Mon, 12/04/2017 - 03:37
Funding Opportunity RFA-CA-18-009 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications from currently funded NCI P01 program projects proposing to expand upon the original research question(s) or otherwise accelerate progress for the parent study by incorporating a new technical approach or instrument developed through support from the NCI Innovative Molecular Analysis Technologies (IMAT) program. Awards from this FOA are meant to incentivize independent validation and accelerate the adoption of these emerging technologies by appropriate research communities. As a component of the NCI IMAT program, this FOA aims to promote interdisciplinary collaboration in the development of innovative tools and methods that enable cancer research and accelerate scientific discovery.
Categories: NIH-Funding

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trials Optional)

NIH Funding Announcements - Mon, 12/04/2017 - 03:37
Funding Opportunity RFA-CA-18-008 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications (formerly called "competing revisions") from currently funded NCI U54 Resource-Related Research Projects proposing to expand upon original research question(s) from specific projects or otherwise accelerate progress for the parent study by incorporating a new technical approach or instrument developed through support from the NCI Innovative Molecular Analysis Technologies (IMAT) program. Awards from this FOA are meant to incentivize independent validation and accelerate the suitability of these emerging technologies for appropriate research communities. As a component of the NCI IMAT program, this FOA aims to promote interdisciplinary collaboration in the development of innovative tools and methods that enable cancer research and accelerate scientific discovery.
Categories: NIH-Funding

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U01 Clinical Trials Optional)

NIH Funding Announcements - Mon, 12/04/2017 - 03:37
Funding Opportunity RFA-CA-18-007 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications (formerly called "competing revisions") from currently funded NCI U01 research projects proposing to expand upon the original research question(s) or otherwise accelerate progress for the parent study by incorporating a new technical approach or instrument developed through support from the NCI Innovative Molecular Analysis Technologies (IMAT) program. Awards from this FOA are meant to incentivize independent validation and accelerate the suitability of these emerging technologies for appropriate research communities. As a component of the NCI IMAT program, this FOA aims to promote interdisciplinary collaboration in the development of innovative tools and methods that enable cancer research and accelerate scientific discovery.
Categories: NIH-Funding

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trials Optional)

NIH Funding Announcements - Mon, 12/04/2017 - 03:37
Funding Opportunity RFA-CA-18-006 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications (formerly called "competing revisions") from currently funded NCI R01 research projects proposing to expand upon the original research question(s) or otherwise accelerate progress for the parent study by incorporating a new technical approach or instrument developed through support from the NCI Innovative Molecular Analysis Technologies (IMAT) program. Awards from this FOA are meant to incentivize independent validation and accelerate the adoption of these emerging technologies by appropriate research communities. As a component of the NCI IMAT program, this FOA aims to promote interdisciplinary collaboration in the development of innovative tools and methods that enable cancer research and accelerate scientific discovery.
Categories: NIH-Funding

By: writedit

WriteEdit-Grant Questions Blog - Sun, 12/03/2017 - 22:59

If your PO did not advise that you resubmit, then you will probably be okay, but you may have to wait until the FY18 budget passes – which probably won’t be until next year. Unfortunately, this delay in making awards for Cycle I grant applications has been going on for well over a decade (maybe two by now?), since it has been that long since Congress had a new budget in place by October 1. I would have thought that with the GOP running both houses of Congress that the budget bill would have been done by December, but obviously there are a few distractions in DC, and the impact of the tax cut act, if they manage to agree on and pass a reconciled version, would need to be taken into consideration. So – if your PO did not advise you to resubmit, all you can do is wait.

Categories: NIH-Funding

By: NCIF30

WriteEdit-Grant Questions Blog - Sun, 12/03/2017 - 22:10

Dear Writedit, first of all, thanks so much for the wonderful blog. It has been so helpful!
I applied to NCI F30 in April and got scored (21st percentile) and reviewed in July. Right away, I contacted my PO, who told me that the funding range for the previous year was 28th percentile but that I would fall in FY2018 and would have to wait until the budget is passed in Congress. I haven’t heard anything since. I know that Congress is still working on the budget, but I am getting a bit nervous and impatient as it has been almost 8 months since I submitted my application… When should I expect to hear back about the funding decision? Is it normal for April submissions to wait this long to hear back? Can I be optimistic of my chances? Any advice?
Thank you!!

Categories: NIH-Funding

By: f31app84

WriteEdit-Grant Questions Blog - Sun, 12/03/2017 - 14:46

Applied to NIDA on an F31 got a 14 and am waiting for a funding determination. Was scored in July and then reviewed September. My PO is being very conservative even though it is in the very low percentiles 4th to be exact. I was told percentiles don’t matter for NIDA. Any word on when we can expect to hear something? I was told early December but our political climatte seems to worsen daily for getting the debt ceiling lifted. I don’t want to keep bothering my PO with these questions when they can’t really tell me anything yet. Now it seems like it could go out until the spring. Any word on whats going on behind the scenes. I am not too experienced with this sort of stuff but am nervous and anxious to see what is going to happen. Any advice would be awesome thank you!

Categories: NIH-Funding

NHLBI Clinical Trial Pilot Studies (R34 - Clinical Trial Optional)

NIH Funding Announcements - Fri, 12/01/2017 - 11:30
Funding Opportunity PAR-18-463 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is to support studies that are essential, yet also sufficient, for investigators to make definitive decisions about the designs of important clinical trials within NHLBI's mission, the prevention and treatment of heart, lung, blood, and sleep disorders. This mechanism may be used to test the feasibility of novel and efficient (pragmatic) trial designs, as well as determine the feasibility of an intervention, intervention parameters, subject availability, or other information essential to complete the design of a trial. Applications should demonstrate that the proposed pilot studies are both necessary and sufficient to permit definitive decisions about the design of the subsequent clinical trial. Applicants who propose solely to write a protocol or manual of operations or to develop infrastructure for a clinical trial will not be considered appropriate for this announcement. The NHLBI anticipates that the R34 award period will yield robust investigator-initiated clinical trial grant applications for the evaluation of interventions for the treatment or prevention of heart, lung, blood, or sleep disorders.
Categories: NIH-Funding

Revision: The NIH Announces New Review Criteria for Career Development Award Applications Involving Clinical Trials

NIH Funding Announcements - Fri, 12/01/2017 - 03:05
Notice NOT-OD-18-109 from the NIH Guide for Grants and Contracts
Categories: NIH-Funding